VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Cardiac involvement in Fabry disease : Jacc review topic of the week
    Pieroni, Maurizio ...
    Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by deficient %-galactosidase A activity that leads to an accumulation of globotriasylceramide (Gb3) in affected ... tissues, including the heart. Cardiovascular involvement usually manifests as left ventricular hypertrophy, myocardial fibrosis, heart failure, and arrhythmias, which limit quality of life and represent the most common causes of death. Following the introduction of enzyme replacement therapy, early diagnosis and treatment have become essential to slow disease progression and prevent major cardiac complications. Recent advances in the understanding of FD pathophysiology suggest that in addition to Gb3 accumulation, other mechanisms contribute to the development of Fabry cardiomyopathy. Progress in imaging techniques have improved diagnosis and staging of FD-related cardiac disease, suggesting a central role for myocardial inflammation and setting the stage for further research. In addition, with the recent approval of oral chaperone therapy and new treatment developments, the FD-specific treatment landscape is rapidly evolving.
    Vir: Journal of the American College of Cardiology. - ISSN 0735-1097 (Vol. 77, no. 7, 23. feb. 2021, p. 922-936)
    Vrsta gradiva - članek, sestavni del
    Leto - 2021
    Jezik - angleški
    COBISS.SI-ID - 57590531

    Povezava(-e):

    https://www.sciencedirect.com/science/article/abs/pii/S0735109720381250#!
    DOI

Vnos na polico